At T2, T3, and T4, a two-cluster solution was identified: resilient and symptomatic
It is not equivalent to an FDA-approved tesamorelin product and no approved ipamorelin drug is represented by this page
Databases searched (and their content coverage dates) were Ovid MEDLINE(R) (1946+ including epub ahead of print, in-process, and other nonindexed citations), Ovid Embase (1974+), Ovid APA PsycInfo (1967+), Ovid Cochrane Central Register of Controlled Trials (1991+), Ovid Cochrane Database of Systematic Reviews (2005+), Web of Science Core Collection via Clarivate Analytics (1975+), and Scopus via Elsevier (1974+)
Analytical Validation, Formulation, and Storage Peptide Sciences and similar vendors supply BPC157 primarily as a lyophilized peptide (e.g., 5 mg vials and capsule formats), labeled exclusively for research use